Brugnera Nunes de Mattos, Alexandra, Mariane Maria Cerneski, Sheila Reichert, and Cassia Nava Jaeger. “Use of Adalimumab, a TNF-Alpha Inhibitor, Is Associated With Paradoxical Psoriasis: Two Clinical Case Reports”. Brazilian Journal of Case Reports 3, no. 2 (January 27, 2023): 12–15. Accessed May 10, 2025. https://www.bjcasereports.com.br/index.php/bjcr/article/view/use_of_adalimumab_a_tnf_alpha_inhibitor.